Mr. José Manuel Beltrán Mendoza
CEO/President
Albek de Mexico S.A. de C.V.
Oriente 4 No. 11
Nuevo Parque Industrial
76809 San Juan del Río , Qro.
MexicoFEI 3009115034Issued Mar 11, 2021Center for Drug Evaluation and Research
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3009115034.
Violations3
Issue DateMar 11, 2021
Product TypeDrugs
StatusOpen
Letter Details
Firm
Albek de Mexico S.A. de C.V.
Location
Mr. José Manuel Beltrán Mendoza
CEO/President
Albek de Mexico S.A. de C.V.
Oriente 4 No. 11
Nuevo Parque Industrial
76809 San Juan del Río , Qro.
Mexico
FEI Number
3009115034
Country
Mexico
Issue Date
March 11, 2021
Issuing Office
Center for Drug Evaluation and Research
Product Type
Drugs
Status
Open
Summary
Albek de Mexico S.A. de C.V. manufactured NEXT ADVANCED ANTIBACTERIAL HAND SANITIZER, an unapproved new drug that was detained at the U.S. border and found to be adulterated due to substance substitution, indicating a failure in quality assurance and compliance with Current Good Manufacturing Practice (CGMP) requirements. The product violated multiple provisions of the Federal Food, Drug, and Cosmetic Act by being introduced into interstate commerce without FDA approval and with false or misleading labeling. FDA laboratory testing of detained batches demonstrated that the company's quality control systems were not functioning adequately to prevent the manufacturing defects.
Albek de Mexico S.A. de C.V. FDA Warning Letter, March 11, 2021